The relationship between the recent outbreak of fusarium keratitis and Bausch & Lomb’s ReNu eye contact solution is becoming clearer as the CDC and the FDA continues its investigation. According to an article in Reuters, “The 57 percent share of cases preliminarily reported for the company’s MoistureLoc formula is significantly and disproportionately higher than its U.S. market share of less than 10 percent,” the company said in a statement.
“This disproportionate representation of MoistureLoc formula in the CDC case reports is the reason Bausch & Lomb voluntarily withdrew … from the market while the investigation to determine the cause of these unusual infections continue,” the company said.
Admitted to practice law in all federal multidistrict litigation courts, the California State Bar and the Florida Bar. His philosophy is to provide aggressive, quality representations and seek fair compensation for individuals and their families who have suffered injury, death, or sexual abuse.
Comments for this article are closed.